Communiqués Adaptive Biotechnologies Corporation

Actions

ADPT

US00650F1093

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 11/09/2026			Varia. 5j.	Varia. 1 janv.
24,20 ^USD	-0,12%		-1,51%	+49,01%

20/08	Adaptive Biotechnologies : un initié cède des actions pour un montant de 3 135 850 $, selon une déclaration à la SEC	MT
30/07	Adaptive Biotechnologies : creusement de la perte au deuxième trimestre malgré une hausse du chiffre d'affaires	MT

Communiqués

01/09	Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference	GL
05/08	Adaptive Biotechnologies : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)	PU
29/07	Adaptive Biotechnologies: Q2 Earnings Snapshot	AQ
29/07	Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results	GL
09/07	Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026	GL
30/06	Adaptive Biotechnologies : Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial	PU
17/06	Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering	GL
15/06	Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses	GL
15/06	Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering	GL
29/05	At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research	GL
21/05	Adaptive Biotechnologies to Participate in Upcoming Investor Conferences	GL
06/05	Adaptive Biotechnologies : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
06/05	Adaptive Biotechnologies : Q1 2026 earnings deck Final	PU
05/05	Adaptive Biotechnologies: Q1 Earnings Snapshot	AQ
05/05	Adaptive Biotechnologies Reports First Quarter 2026 Financial Results	GL
15/04	Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026	GL
25/03	Adaptive Biotechnologies : 2026 Adaptive Investor Presentation (278910)	PU
05/02	Adaptive Biotechnologies : ADPT 4Q25 Earnings Slides	PU
05/02	Adaptive Biotechnologies: Q4 Earnings Snapshot	AQ
05/02	Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results	GL
05/02	Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results	AQ
27/01	Adaptive Biotechnologies to Participate in Upcoming Investor Conferences	GL
22/01	Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026	GL
12/01	Adaptive Biotechnologies : ADPT JPM Presentation	PU
12/01	Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results	GL